DE60239895D1 - Humanisierte super-antikörper - Google Patents
Humanisierte super-antikörperInfo
- Publication number
- DE60239895D1 DE60239895D1 DE60239895T DE60239895T DE60239895D1 DE 60239895 D1 DE60239895 D1 DE 60239895D1 DE 60239895 T DE60239895 T DE 60239895T DE 60239895 T DE60239895 T DE 60239895T DE 60239895 D1 DE60239895 D1 DE 60239895D1
- Authority
- DE
- Germany
- Prior art keywords
- humanized
- antibodies
- super
- super antibodies
- humanized super
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/022011 WO2004006955A1 (en) | 2001-07-12 | 2002-07-12 | Super humanized antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60239895D1 true DE60239895D1 (de) | 2011-06-09 |
Family
ID=43969199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60239895T Expired - Lifetime DE60239895D1 (de) | 2002-07-12 | 2002-07-12 | Humanisierte super-antikörper |
Country Status (4)
Country | Link |
---|---|
AT (1) | ATE506966T1 (de) |
DE (1) | DE60239895D1 (de) |
DK (1) | DK1539233T3 (de) |
ES (1) | ES2370225T3 (de) |
-
2002
- 2002-07-12 ES ES02752269T patent/ES2370225T3/es not_active Expired - Lifetime
- 2002-07-12 DE DE60239895T patent/DE60239895D1/de not_active Expired - Lifetime
- 2002-07-12 AT AT02752269T patent/ATE506966T1/de active
- 2002-07-12 DK DK02752269.7T patent/DK1539233T3/da active
Also Published As
Publication number | Publication date |
---|---|
ES2370225T3 (es) | 2011-12-13 |
ATE506966T1 (de) | 2011-05-15 |
DK1539233T3 (da) | 2011-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20044347L (no) | Anti-alfavbeta6-antistoff | |
CY2012019I2 (el) | Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20 | |
EE200300179A (et) | Humaniseeritud LT-ß-R-i vastased antikehad | |
DK1599504T3 (da) | Modificeret antistof | |
NO2016001I2 (no) | Trastuzumab emtansin | |
DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
IS6982A (is) | Mótefni gegn VLA-1 | |
DK1501856T3 (da) | Anti-HER2 antistofvarianter | |
HRP20151252T4 (hr) | Modificirani fab ulomci protutijela | |
PL2177537T3 (pl) | Przeciwciała przeciw MadCAM | |
IL166244A0 (en) | Super humanized antibodies | |
ATE465180T1 (de) | Therapeutische anti-igfr1-antikörper- kombinationen | |
ATE549033T1 (de) | Therapeutischer menschlicher monoklonaler anti-il-1r1-antikörper | |
NO20071430L (no) | Anti-OX4OL antistoffer | |
EP1499352A4 (de) | Rekombinante anti-interleukin-9-antikörper | |
ATE480564T1 (de) | Monoklonaler anti-mensch-tenascin-antikörper | |
EP1461001A4 (de) | Mit krebs assoziiertes epitop | |
EP1664117A4 (de) | Immunogen | |
EE200300569A (et) | CD44v6-spetsiifilised antikehad | |
AU2003277832A8 (en) | Humanized tissue factor antibodies | |
BRPI0509495A2 (pt) | anticorpo humanizado | |
FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
DE60239895D1 (de) | Humanisierte super-antikörper | |
ATE535259T1 (de) | Immunogener, monoklonaler antikörper |